Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Corvus Pharma Com
(NQ:
CRVS
)
4.300
+0.150 (+3.61%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
231,293
Open
4.200
Bid (Size)
4.100 (70)
Ask (Size)
4.300 (20)
Prev. Close
4.150
Today's Range
4.046 - 4.300
52wk Range
1.050 - 4.300
Shares Outstanding
62,551,281
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Fortinet Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
August 07, 2024
Via
Benzinga
The 2024 Millionaire’s Club: 3 Penny Stocks to Buy Now
May 31, 2024
One of the best ways to spot opportunity in penny stocks to buy is by following insiders. Here are three to consider.
Via
InvestorPlace
Performance
YTD
+144.32%
+144.32%
1 Month
+86.15%
+86.15%
3 Month
+112.87%
+112.87%
6 Month
+86.96%
+86.96%
1 Year
+107.73%
+107.73%
More News
Read More
CRVS Stock Earnings: Corvus Pharma Misses EPS for Q1 2024
May 06, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 09, 2024
Via
Benzinga
CRVS Stock Earnings: Corvus Pharma Misses EPS for Q4 2023
March 19, 2024
Via
InvestorPlace
Earnings Outlook For Corvus Pharma
March 18, 2024
Via
Benzinga
Preview: Corvus Pharma's Earnings
November 06, 2023
Via
Benzinga
Earnings Scheduled For March 19, 2024
March 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 09, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 08, 2024
Via
Benzinga
Corvus Pharmaceuticals Announces the Passing of Board Member Edith P. Mitchell
January 23, 2024
From
Corvus Pharmaceuticals, Inc.
Via
GlobeNewswire
Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket
December 11, 2023
Via
Benzinga
Corvus Pharmaceuticals Presents New Interim Soquelitinib Data from its Phase 1/1b T Cell Lymphoma Trial
December 09, 2023
From
Corvus Pharmaceuticals, Inc.
Via
GlobeNewswire
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2023 Financial Results
November 07, 2023
From
Corvus Pharmaceuticals, Inc.
Via
GlobeNewswire
Corvus Pharmaceuticals to Present New Interim Soquelitinib Data from its Phase 1/1b T Cell Lymphoma Trial at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition
November 02, 2023
From
Corvus Pharmaceuticals, Inc.
Via
GlobeNewswire
Corvus Pharmaceuticals Announces Publication of Preclinical Data Demonstrating Potential of ITK Inhibition with Soquelitinib as a Novel Approach to T Cell-Mediated Inflammatory and Immune Diseases
November 01, 2023
From
Corvus Pharmaceuticals, Inc.
Via
GlobeNewswire
Corvus Pharmaceuticals to Provide Business Update and Report Third Quarter Financial Results on November 7, 2023
October 31, 2023
From
Corvus Pharmaceuticals, Inc.
Via
GlobeNewswire
Why Toro Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
September 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 06, 2023
Via
Benzinga
Corvus Pharmaceuticals Confirms Planned Initiation of Soquelitinib (CPI-818) Phase 3 Registrational Clinical Trial in Peripheral T Cell Lymphoma Following Meeting with FDA
September 06, 2023
From
Corvus Pharmaceuticals, Inc.
Via
GlobeNewswire
Corvus Pharmaceuticals Eyes Expansion Of Blood Cancer Therapy but Resource Limitations Pose Challenge: Oppenheimer
August 18, 2023
Via
Benzinga
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results
August 08, 2023
From
Corvus Pharmaceuticals, Inc.
Via
GlobeNewswire
Corvus Pharmaceuticals to Provide Business Update and Report Second Quarter Financial Results on August 8, 2023
August 01, 2023
From
Corvus Pharmaceuticals, Inc.
Via
GlobeNewswire
Why Icahn Enterprises Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 10, 2023
Via
Benzinga
Corvus Pharmaceuticals Announces Publication of Preclinical Data Demonstrating Potential Novel Approach to Immunotherapy Based on Inhibition of ITK with Soquelitinib (CPI-818)
July 06, 2023
From
Corvus Pharmaceuticals, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.